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Neonatal hyperbilirubinemia (NNH) or jaundice is one of the most common conditions that demand medical attention in newborns [1]. It is observed in the 1st week of 
life in approximately 60% of term and 80% of preterm infants [2]. 
According to the American Academy of Pediatrics (AAP), it was 
estimated that every newborn develops an unconjugated serum 
bilirubin level of >30 µmol/L (1.8 mg/dL) during the 1st week 
of life [3]. After delivery, newborns are early discharged from 
the hospital because of medical, social, and economic reasons. 
However, after some time, readmission occurs because of NNH. 
The AAP recommends that newborns discharged within 48 h 
should have a follow-up visit after 2–3 days to detect significant 
jaundice and other problems [3]. This recommendation is not 
always possible in our country due to limited follow-up facilities 
in the community.
NNH needs appropriate and timely intervention because if 
left untreated, it may lead to serious complications such as the 
development of neurologic dysfunction which includes, acute 
and chronic (kernicterus) bilirubin-induced encephalopathy [4]. 
Prevention of these complications depends on the time of detection 
and effective early treatment. In the recent years, many efforts have 
been made to identify those infants, which are likely to develop 
neonatal jaundice. One of the most common measures used for 
the identification of jaundice is the clinical examination; however, 
it is not a reliable measure for the estimation of serum bilirubin. 
Hence, alternative strategies should be developed to predict the risk 
of significant jaundice as they can reduce hospital stay for normal 
babies and identify significant NNH that may happen in the future.
There are some reliable strategies to identify jaundiced neonates 
after delivery. These are universal follow-up within 1–2 days of 
early discharge, umbilical cord bilirubin concentration at birth, 
routine predischarge serum bilirubin, transcutaneous bilirubin 
measurement, and the universal clinical assessment of risk factors 
of developing jaundice [5]. Among these methods, estimation of 
cord bilirubin levels at delivery is the most commonly used as it 
is cheap, practical, an easy to perform and may offer an attractive 
predictive marker for hyperbilirubinemia occurring later on. 
Hence, it would be convenient to be able to predict the risk of 
jaundice to implement safe, cost-effective, and early treatment 
and thereby minimize the risk of bilirubin dependent brain 
damage. Hence, the present study was undertaken to evaluate 
the predictive ability of cord bilirubin levels for the subsequent 
development of significant NNH in healthy term neonates.
MATERIALS AND METHODS
This prospective study was conducted in the Department of 
Paediatrics and Obstetrics and Gynaecology of a tertiary care 
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teaching hospital of central India during 1 year period from 
March 2015 to February 2016. Ethical clearance was obtained 
from the Institutional Ethical Committee. Written informed 
consent was taken from the parents/caregivers of the neonates. 
In this study, 200 healthy, full-term neonates between gestational 
age 37–42 weeks, born consecutively at the obstetrics department 
were included in the study. The babies admitted to neonatal 
intensive care unit and showing any signs of complication or 
congenital anomaly were excluded from the study.
A thorough antenatal, perinatal, and natal history was 
obtained and recorded in a predesigned pro forma. Cord blood 
was collected from all newborns, fulfilling the inclusion criteria, 
and the samples were sent to the ward-side laboratory for the 
estimation of serum bilirubin and to the blood bank for blood 
grouping and Rh typing.
Cord Blood Sampling
After birth, the cord was clamped and then cut. The blood 
was collected in a serum separator vial following all aseptic 
precautions and then centrifuged in a machine at a speed of 
200 rpm for 5 min. The centrifuged serum was sent to laboratory 
for total serum bilirubin and unconjugated bilirubin estimation. 
The noncentrifuged, ethylene diamine tetra acetate sample 
was sent for blood grouping and Rh typing. All neonates were 
assessed clinically following the birth for up to 7 postnatal days 
for the development of jaundice. They were also assessed for the 
presence of risk factors, related to the development of neonatal 
jaundice.
Total Serum Bilirubin Estimation
It was done within 12 h of collection of the sample by the 
diazotized sulfanilic test. This method for bilirubin estimation is 
based on the principle that bilirubin in the sample reacts with the 
diazotized sulfanilic acid in acidic medium to form a pink colored 
complex that can be measured by spectrophotometry. The color of 
the complex is directly proportional to bilirubin concentration of 
the sample. There are two methods for the measurement of serum 
bilirubin: Direct and indirect. Direct Bilirubin, reacts directly in 
acidic medium because of water-soluble nature, whereas indirect 
or unconjugated bilirubin being water insoluble is solubilized 
using a surfactant and then it reacts similarly to direct bilirubin. 
The “direct” and “indirect” bilirubin is only approximately 
equivalent to the conjugated and unconjugated fractions [6].
Statistical Analysis
Data were analyzed using Statistical Package for Social Sciences 
(SPSS Inc., Chicago, version 22.0). Continuous variables were 
presented as mean for parametric data and median for non-
parametric data. Student’s t-test and Mann–Whitney were applied 
to calculate the statistical significance of normative data and 
non-normative data, respectively. Categorical variables were 
expressed as frequencies and percentages. Nominal-categorical 
data between the groups were compared using Chi-square test or 
Fisher’s exact test as appropriate. The p<0.05 were considered 
statistically significant. Minitab version 17 is used for computation 
of statistics.
RESULTS
A total of 200 mothers and neonates were included in the study. 
Out of 200 mothers, 78.5% were between 20 and 30 years, and 
55.5% belonged to urban area. Cord blood bilirubin (CBB) 
was measured, and a cutoff of 2.5 mg/dl was set. Among 200 
neonates, 157 have CBB <2.5 mg/dl and the rest 43 have CBB 
>2.5 mg/dl. Several risk factors were assessed for the signs of 
jaundice and statistical significance with CBB was estimated. 
Among 200 neonates, 55% were male babies, and 77% babies 
have >2.5 kg birth weight. Among 200 neonates, 120 developed 
jaundice. Among 120 neonates, 47% have developed jaundice 
between 48 and 72 h, 42% have extent till legs. Nearly 75.5% 
neonates did not require referral and 91% neonates have jaundice 
in their siblings. Among the above variables, gender difference 
(p<0.05), development of jaundice (p=0.00), extent of jaundice 
(p=0.00), number of cases requiring referral (p<0.05), and 
jaundice development in siblings (p=0.01) were found statistically 
significant in relation to CBB >2.5 mg/dl (Table 1).
 Several maternal and neonatal factors that can affect CBB 
were assessed. Among maternal factors, maternal history 
of jaundice (p=0.009), gestational hypertension (p=0.01), 
antepartum hemorrhage (APH) (p<0.05), obstructed labor 
(p=0.009), and use of oxytocin (p=0.008) during labor were 
found to be significantly and statistically associated with CBB 
>2.5 mg/dl. Among neonatal factors, ABO incompatibility and 
Rh incompatibility, both were significantly associated with CBB 
>2.5 mg/dl (p=0.001) (Table 2).
 In the above study, at CBB cutoff of 2.5 mg/dl, sensitivity was 
33.33%, specificity was 96.25%, positive likelihood ratio was 
8.89, negative likelihood ratio was 0.69, positive predictive value 
was 93.02% and negative predictive value was 49.04% (Table 3).
Logistic regression was calculated for clinical jaundice based 
on CBB and regression coefficient of 0.6638 was obtained 
(p=0.011), (Table 4).
Fig. 1 showing the probability of development of clinical 
jaundice. It was shown in line graph: As the CBB increases, 
probability of occurrence of clinical jaundice also increases.
DISCUSSION
Jaundice or hyperbilirubinemia is a clinical condition that is 
caused due to the elevated serum concentration of bilirubin. 
In neonates, it is one of the major causes of concern. Its early 
detection is very difficult as neonatal jaundice may not appear 
until serum bilirubin exceeds 5 to 7 mg/dl [7]. In the present study, 
there were 110 males and 90 female neonates, and the occurrence 
of NNH was significantly more among female neonates. These 
findings were consistent with the study done by Garosi et al. [8], 
Maisels and Kring [9], Satrya et al. [10], whereas Boskabadi 
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et al. [11] found that bilirubin level was higher among male 
newborns. Taksande et al. [12], Rostami and Mehrabi [5] and 
Rajpurohit et al. [13] found no correlation. Veni concluded that 
male newborns are always more susceptible to NNH because of 
higher metabolic rate. This theory is enforced by the fact that 
XY blastocysts and embryos grow at an accelerated rate when 
compared with XX chromosome bearers [14].
In our study, birth weight was not associated with NNH. This 
finding was in concordance with the many previous studies where 
they found no correlation between the NNH and the birth weight 
of the newborn [14-17]. The appearance of clinical jaundice and 
the extent of jaundice were significantly correlated with CBB. 
In addition, higher CBB was significantly associated with the 
number of cases required referral for the management of NNH. 
This finding was consistent with studies done by Nahar et al. [18], 
Zeitoun et al. [7], Ipek et al. [19], Farhat et al. [20], Trivedi 
et al. [21], Chary et al. [22], Dwarampudi and Ramakrishna [23], 
and Ahire et al. [24]. This suggests that higher the CBB, more 
Table 2: Maternal and neonatal factors affecting CBB
Factors Variables CBB (<2.5) n=157 CBB>2.5 n=43 p value
Maternal factors History of jaundice 1 3 *0.009
Gestational hypertension 22 10 *0.0143
Eclampsia 5 3 0.373
Preeclampsia 11 5 0.344
APH 7 10 *<0.05
PROM 7 3 0.451
Obstructed labor 20 0 *0.009
Oligohydriamnios 6 0 0.344
Oxytocin 4 6 *0.008
Fetal distress 34 10 0.975
Neonatal factors ABO incompatibility 27 18 *0.001
Rh incompatibility 1 4 *0.001
PROM: Premature rupture of membranes, *denotes statistical significance (p<0.05). CBB: Cord blood bilirubin, APH: Antepartum hemorrhage
Table 1: Risk factors and their association with CBB level
Variable CBB<2.5 (n=157) CBB>2.5 (n=43) Total (%) p value (Chi‑square test)
Gender
Female 59 31 90 (45) *<0.05
Male 98 12 (11%) 110 (55)
Birth weight
1.8–2.0 kg 8 0 8 (4) ♦0.37
2.0–2.5 kg 30 8 38 (19)
>2.5 kg 119 35 154 (77)
Development of jaundice (120 neonates)
<24 h 0 7 7 (5.8) *0.00
24–48 h 21 21 42 (35)
48–72 h 46 10 56 (46.6)
>72 h 13 2 15 (12.6)
Extent of jaundice
Up to face 13 3 16 (13.3) *0.00
Up to chest 13 7 20 (16.7)
Up to abdomen 2 10 12 (10)
Up to legs 42 8 50 (42)
Up to sole 10 12 22 (18)
Referral required
No 139 12 151 (75.5) *<0.05
Yes 18 31 49 (24.5)
Jaundice in siblings
No 147 35 182 (91) *0.014
Yes 10 8 18 (9)
CBB: Cord blood bilirubin, *denotes statistical significance (p<0.05), ♦: Fisher exact test applied
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likely and earlier the child will develop jaundice and will require 
referral for intervention for its management.
We found a significant association between the maternal 
history of jaundice, gestational hypertension, induction of labor 
with oxytocin, APH, obstructed labor with the development 
of NNH (p<0.05). In a case of obstructed labor, there are high 
chances of injury to the baby and hence bleeding, which makes 
a newborn susceptible to develop NNH. CBB and subsequent 
development of NNH were not found to be associated with 
the maternal history of eclampsia and preeclampsia. The 
contradictory results were observed in a study done by Taskande 
et al., where they found no significant differences between the 
development of significant NNH with maternal oxytocin use, as 
well as PIH in mother, feeding pattern, and hematocrit level [12]. 
Induction of labor with use of oxytocin was found significant 
in previous studies also [8,12-16,25-27]. This can be explained 
by the fact that oxytocin has anti-diuretic and saluretic effects, 
which causes maternal hypo-osmolality and hyponatremia. These 
biochemical changes are aggravated by the infusion of oxytocin 
with electrolyte free dextrose solution. This hypo-osmolality gets 
transferred transplacentally in the fetal blood and causes osmotic 
fragility of the red blood cells. These swollen, hyper-fragile 
erythrocytes get easily destroyed in spleen and result in increased 
bilirubin production [26].
In our study, CBB, at a cutoff value of 2.5 mg/dl, had a 
sensitivity of 33.33%, specificity of 96.25%, positive predictive 
value was 93.02%, and negative predictive value of 49.04%. 
This finding was consistent with the previous studies [7,19-24]. 
Taksande et al. [12] showed that the CBB >2 mg/dl has a 
sensitivity of 89.5%, specificity of 85%, negative predictive value 
of 98.7%, and positive predictive value of 38.8%. Nahar et al. [7] 
showed that the cord bilirubin level ≥2.5 mg/dl has a sensitivity 
77%, specificity 98.6%, with negative predictive value of 96%.
There were few limitations our study such as we could not 
do a long-term follow-up which is necessary in these neonates. 
In addition, we have enrolled only term neonates; therefore, the 
results of this study cannot be generalized to preterm neonates. 
Hence, a trial that enrolls both term and preterm neonates in a 
sufficient number should be conducted in future.
CONCLUSION
NNH and CBB level were found to be associated with, several 
maternal and neonatal risk factors like ABO Incompatibility, Rh 
incompatibility, sibling’s history of jaundice, and maternal history 
of jaundice, Gestational hypertension, antepartum hemorrhage, 
Table 3: Sensitivity and specificity of CBB (at 2.5 mg/dl)
Statistic Value 95% CI
Sensitivity 33.33% 24.99–42.52%
Specificity 96.25% 89.43–99.22%
Positive likelihood ratio 8.89 2.85–27.76
Negative likelihood ratio 0.69 0.61–0.79
Positive predictive value 93.02% 80.94–98.54%
Negative predictive value 49.04% 40.99–57.14%
CBB: Cord blood bilirubin, CI: Confidence interval
Figure 1: Probability of development of clinical jaundice
Table 4: Logistic regression of development of clinical jaundice
Statistic Intercept CBB
Regression coefficient −1.0103 0.6638
Standard error 0.4419 0.2028
OR - 1.9422
OR low - 1.3053
OR high - 2.8900
p value 0.0222 *0.0011
*Denotes statistical significance (p<0.05). CBB: Cord blood bilirubin, OR: Odds ratio
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and maternal oxytocin use. Estimation of CBB should be 
considered as a strategy for early identification of those at risk of 
neonatal jaundice, which in turn could drive a more appropriate 
and timely utilization of healthcare resources.
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